Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
CYTOKIND: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PROVIDE CLINICAL VALIDATION FOR THE TREATMENT OF COVID WITH NB-UVB THERAPY. A SUBMISSION TO THE FDA FOR A NEW INDICATION WILL BE MADE.
Task order obligations
Estimated months remaining until end of performance.
Period of performance
100% of period elapsed
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|